<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><copyright>Copyright 2010 Medical News Today</copyright><description>Latest Health News and Medical News posted throughout the day, every day.</description><link>http://www.medicalnewstoday.com/sections/lupus/</link><title>Lupus News From Medical News Today</title><webMaster>admin&#064;medicalnewstoday.com  (MNT Admin)</webMaster><managingEditor>editors&#064;medicalnewstoday.com  (MNT Editors)</managingEditor><language>en-us</language>
<item><title>TAU Expert Reviews Environmental Triggers (hairspray! Lipstick!) Of Common Autoimmune Diseases</title><pubDate>Tue, 26 Jan 2010 05:00:00 PST</pubDate><link>http://mnt.to/f/3wNp</link><guid>http://mnt.to/f/3wNp</guid><description>The links between autoimmune diseases, infections, genetics and the environment are complex and mysterious...</description><category domain="http://www.medicalnewstoday.com/sections/arthritis/">Arthritis / Rheumatology</category></item>
<item><title>New Therapeutic Approach Identified For Kidney Disease Associated With Lupus</title><pubDate>Tue, 26 Jan 2010 01:00:00 PST</pubDate><link>http://mnt.to/f/3wLt</link><guid>http://mnt.to/f/3wLt</guid><description>Investigators have identified a new disease mechanism and therapeutic approach for a type of advanced kidney disease that is a common cause of complications in patients with lupus. The study was led by investigators at Hospital for Special Surgery and appears in the January 25 online Early Edition of the Proceedings of the National Academy of Sciences...</description><category domain="http://www.medicalnewstoday.com/sections/urology-nephrology/">Urology / Nephrology</category></item>
<item><title>The Lupus Foundation Of America Seeks Applications For Its 2010 Gina M. Finzi Memorial Student Summer Fellowship Program</title><pubDate>Wed, 13 Jan 2010 12:00:00 PST</pubDate><link>http://mnt.to/f/3wg9</link><guid>http://mnt.to/f/3wg9</guid><description>The Lupus Foundation of America, Inc. (LFA) is seeking applications for its 2010 Gina M. Finzi Memorial Student Summer Fellowship Program. The purpose of these awards is to foster an interest among young investigators in lupus research under the supervision of an established in investigator...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Epratuzumab Receives U.S. Patent &#45; Lupus Foundation Of America, Inc.</title><pubDate>Tue, 12 Jan 2010 03:00:00 PST</pubDate><link>http://mnt.to/f/3wbB</link><guid>http://mnt.to/f/3wbB</guid><description>A U.S. patent has been issued to Immunomedics, Inc. for epratuzumab, a monoclonal antibody under development as a potential new treatment for lupus.  In August of 2009, Immunomedics and its partner, UCB of Belgium, reported promising data from a phase IIb clinical study of epratuzumab involving 227 individuals with moderate to severe lupus. Learn more about these results...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Genomes Of Identical Twins Reveal Epigenetic Changes That May Play Role In Lupus</title><pubDate>Mon, 28 Dec 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3vKk</link><guid>http://mnt.to/f/3vKk</guid><description>Identical twins look the same and are nearly genetically identical, but environmental factors and the resulting cellular changes could cause disease in one sibling and not the other. In a study published online in Genome Research (www.genome...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Julian Lennon And James Scott Cook Raise Awareness And Funds For Lupus Research</title><pubDate>Wed, 02 Dec 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3tTY</link><guid>http://mnt.to/f/3tTY</guid><description>Julian Lennon, son of the legendary John Lennon, and James Scott Cook announced today that they will donate a portion of the proceeds from their song, "LUCY," to fund research on the disease lupus...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>$3.6 Million Awarded To Drive Innovative Science In Lupus And Autoimmunity</title><pubDate>Thu, 26 Nov 2009 01:00:00 PST</pubDate><link>http://mnt.to/f/3tJL</link><guid>http://mnt.to/f/3tJL</guid><description>The Lupus Research Institute (LRI) has named 12 new grant recipients for 2009. The awards, totaling $3.6 million, recognize innovative work across a broad spectrum of lupus research. All were selected for their creativity, novelty, and potential to drive scientific discovery to ultimately prevent, treat, and cure the complex disease of systemic lupus...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>ImmuPharma Announces Final Results Of PhaseIIb Study Of LUPUZOR&#x2122; In Lupus</title><pubDate>Mon, 23 Nov 2009 03:00:00 PST</pubDate><link>http://mnt.to/f/3tBd</link><guid>http://mnt.to/f/3tBd</guid><description>ImmuPharma PLC announced the final results from a Phase IIb trial of LUPUZOR&#x2122; in active patients with Systemic Lupus Erythematosus (SLE). Lupuzor&#x2122; administered at 200 mcg once&#45;a&#45;month for 3 months plus standard of care achieved a clinically significant improvement in patient response rate as measured by the combined score compared to placebo plus standard of care...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Saliva Proteins Change As Women Age</title><pubDate>Fri, 20 Nov 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3tsZ</link><guid>http://mnt.to/f/3tsZ</guid><description>In a step toward using human saliva to tell whether those stiff joints, memory lapses, and other telltale signs of aging are normal or red flags for disease, scientists are describing how the protein content of women's saliva change with advancing age...</description><category domain="http://www.medicalnewstoday.com/sections/womens_health/">Women's Health / Gynecology</category></item>
<item><title>ImmuPharma PLC: Encouraging Final Phase IIb Results Seen With LUPUZOR&#x2122; In Systemic Lupus Erythematosus</title><pubDate>Thu, 19 Nov 2009 18:00:00 PST</pubDate><link>http://mnt.to/f/3tt4</link><guid>http://mnt.to/f/3tt4</guid><description>ImmuPharma PLC (LSE:IMM) the specialist discovery and development pharmaceutical company is pleased to announce the final results from a Phase IIb trial of LUPUZOR&#x2122; in active patients with Systemic Lupus Erythematosus (SLE)...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Smokers With Common Autoimmune Disorder At Higher Risk For Skin Damage</title><pubDate>Wed, 04 Nov 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3sHc</link><guid>http://mnt.to/f/3sHc</guid><description>As if there weren't enough reasons to stop smoking, a team of researchers at the Research Institute of the McGill University Health Centre (RI&#45;MUHC) have just found another. A study led by Dr. Christian A Pineau, Co&#45;Director of the Lupus and Vasculitis clinic at the MUHC, has clearly linked skin damage and rashes to smoking in people with systemic lupus erythematosus (SLE)...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Promise Of A New Lupus Treatment Is A Groundbreaking Achievement</title><pubDate>Tue, 03 Nov 2009 07:00:00 PST</pubDate><link>http://mnt.to/f/3sG3</link><guid>http://mnt.to/f/3sG3</guid><description>Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS&#45;76, the second of two large&#45;scale phase III clinical trials of BENLYSTA&#x2122; (belimumab) for treating systemic lupus. A full presentation of results from BLISS&#45;52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Lupus Research Institute: Benlysta(TM) Trial Results In An Historic Research Breakthrough And Victory For People With Lupus</title><pubDate>Tue, 03 Nov 2009 02:00:00 PST</pubDate><link>http://mnt.to/f/3sDB</link><guid>http://mnt.to/f/3sDB</guid><description>The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences (HGS) and GlaxoSmithKline for achieving an historical landmark &#45; the second positive phase 3 clinical trial of Benlysta (belimumab), the first successfully tested new drug developed specifically for people with systemic lupus...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>BENLYSTA&#x2122; Successful In Second Pivotal Clinical Trial</title><pubDate>Tue, 03 Nov 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3sCC</link><guid>http://mnt.to/f/3sCC</guid><description>Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) announced positive results from BLISS&#45;76, the second of two large&#45;scale phase III clinical trials of BENLYSTA&#x2122; (belimumab) for treating systemic lupus. A full presentation of results from BLISS&#45;52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Lupus Patients Who Receive Kidney Transplants Rarely Develop Lupus Nephritis</title><pubDate>Mon, 02 Nov 2009 03:00:00 PST</pubDate><link>http://mnt.to/f/3sBC</link><guid>http://mnt.to/f/3sBC</guid><description>Individuals with a history of lupus who receive a kidney transplant rarely develop the serious inflammatory condition lupus nephritis in their new organ, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA...</description><category domain="http://www.medicalnewstoday.com/sections/transplants/">Transplants / Organ Donations</category></item>
<item><title>Cellular Mechanism That Causes Lupuslike Symptoms In Mice Identified By Stanford Study</title><pubDate>Mon, 19 Oct 2009 04:00:00 PST</pubDate><link>http://mnt.to/f/3rVs</link><guid>http://mnt.to/f/3rVs</guid><description>Macrophages, the scavenger cells of the body's immune system, are responsible for disposing of dying cells. Stanford University School of Medicine researchers have identified one pathway in this important process in mice that, if disrupted, causes a lupuslike autoimmune disease...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Lupus Patients Perceive Benefit From Cardiovascular Disease Prevention Counseling Program</title><pubDate>Mon, 19 Oct 2009 01:00:00 PST</pubDate><link>http://mnt.to/f/3rT7</link><guid>http://mnt.to/f/3rT7</guid><description>According to a new study by Hospital for Special Surgery investigators presented at the American College of Rheumatology meeting on October 21 in Philadelphia, most lupus patients are not aware that their condition puts them at a higher risk for cardiovascular disease and a counseling program is a valuable way to promote education and lifestyle change...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>National Report Shines Light On Lupus 50&#45;Year Treatment Drought</title><pubDate>Wed, 07 Oct 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3rjS</link><guid>http://mnt.to/f/3rjS</guid><description>The Lewin Group, a national health care consulting firm, has issued recommendations on ways to overcome the barriers that have obstructed lupus drug development resulting in no new drug approval for this disease in more than 50 years &#45; since the Eisenhower Administration...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>The Lupus Foundation Of America Urges Key Stakeholders To Implement Report Recommendations</title><pubDate>Tue, 06 Oct 2009 09:00:00 PST</pubDate><link>http://mnt.to/f/3rhL</link><guid>http://mnt.to/f/3rhL</guid><description>The Lewin Group, a national health care consulting firm, issued recommendations on ways to overcome the barriers that have obstructed lupus drug development resulting in no new drug approval for this disease in more than 50 years&#45; since the Eisenhower Administration...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Young Women With Autoimmune Condition Need To Be Warned About The Dangers Of Smoking And Use Of Oral Contraceptives</title><pubDate>Mon, 28 Sep 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3qS6</link><guid>http://mnt.to/f/3qS6</guid><description>An article published Online First and in the November edition of The Lancet Neurology reports that women with a particular subtype of antibody called lupus anticoagulant (LA) have a more than 40&#45;fold increased risk of stroke. Moreover, they have a 5&#45;fold increased risk of heart attack compared with the general population of young women...</description><category domain="http://www.medicalnewstoday.com/sections/neurology/">Neurology / Neuroscience</category></item>
<item><title>The Lupus Foundation Of America, Inc. Asks Supporters To Band Together For Lupus</title><pubDate>Wed, 23 Sep 2009 01:00:00 PST</pubDate><link>http://mnt.to/f/3qFR</link><guid>http://mnt.to/f/3qFR</guid><description> It's been 50 years since the U.S. Food and Drug Administration (FDA) approved a medication to treat lupus &#45;&#45; when Dwight D. Eisenhower was President! To highlight the need for safer, more tolerable, and effective medications, the Lupus Foundation of America, Inc...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Race Shown To Affect Severity Of Lupus Disease</title><pubDate>Wed, 09 Sep 2009 02:00:00 PST</pubDate><link>http://mnt.to/f/3q2N</link><guid>http://mnt.to/f/3q2N</guid><description>In patients with systemic lupus erythematosus, their race can affect how severe the disease will become, according to a new study. Systemic lupus erythematosus (SLE) is the most common form of lupus a chronic inflammatory disease that can affect various parts of the body, especially the kidneys, joints, blood and nervous system...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Novel Evidence&#45;Based SLE Responder Index Described In Peer Reviewed Publication As Potentially Significant Advance In Lupus Drug Development</title><pubDate>Mon, 07 Sep 2009 03:00:00 PST</pubDate><link>http://mnt.to/f/3pXB</link><guid>http://mnt.to/f/3pXB</guid><description>Human Genome Sciences, Inc. (NASDAQ:HGSI) announced publication by the journal  of an article describing the development and use of a novel evidence&#45;based systemic lupus erythematosus (SLE) Responder Index selected as the primary endpoint of two pivotal Phase 3 clinical trials of BENLYSTA&#x2122; (belimumab) in serologically active patients with SLE...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>Shortage Of Lupus Patients Challenges Growing Number Of Clinical Studies</title><pubDate>Wed, 02 Sep 2009 23:00:00 PST</pubDate><link>http://mnt.to/f/3pMD</link><guid>http://mnt.to/f/3pMD</guid><description>It has been more than 50 years since the U.S. Food and Drug Administration (FDA) last approved a new medicine specifically for lupus &#45; when Dwight D. Eisenhower was president. Existing treatments have been "borrowed" from other disorders and the risk/benefit ratio of these treatments is far from optimal. However, hope is on the horizon...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
<item><title>UCB And Immunomedics Announce Positive Results For Epratuzumab Phase IIb Study In Systemic Lupus Erythematosus (SLE)</title><pubDate>Fri, 28 Aug 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3pwH</link><guid>http://mnt.to/f/3pwH</guid><description>UCB and Immunomedics (NASDAQ: IMMU) announced top&#45;line results from UCB's Phase IIb clinical study comparing epratuzumab to placebo in patients with systemic lupus erythematosus (SLE, also commonly known as lupus). The data from the 12&#45;week dose and regimen&#45;ranging study demonstrated clinical meaningful treatment effect of epratuzumab over placebo in SLE patients...</description><category domain="http://www.medicalnewstoday.com/sections/lupus/">Lupus</category></item>
</channel></rss>